{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:57:32Z","timestamp":1759010252697,"version":"3.37.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.biologicals.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T17:17:05Z","timestamp":1467047825000},"page":"276-280","source":"Crossref","is-referenced-by-count":11,"title":["Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?"],"prefix":"10.1016","volume":"44","author":[{"given":"K.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Brasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nohynek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Neels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2016.04.007_bib1","unstructured":"EMA twenty-second pandemic pharmacovigilance update. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2010\/08\/WC500095870.pdf."},{"key":"10.1016\/j.biologicals.2016.04.007_bib2","unstructured":"Press release 27\/08\/2010 European Medicines Agency starts review of Pandemrix \u2013 agency is investigating whether there is a link between vaccine and cases of narcolepsy. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/08\/news_detail_001105.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1."},{"key":"10.1016\/j.biologicals.2016.04.007_bib3","unstructured":"EMA Eudravigilance. https:\/\/eudravigilance.ema.europa.eu\/highres.htm."},{"issue":"3","key":"10.1016\/j.biologicals.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"issue":"Pt 8","key":"10.1016\/j.biologicals.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","author":"Dauvilliers","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.biologicals.2016.04.007_bib6","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.biologicals.2016.04.007_bib7","first-page":"15","article-title":"Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009\u2013December 2010","volume":"19","author":"O'Flanagan","year":"2014","journal-title":"Euro Surveillance"},{"issue":"9","key":"10.1016\/j.biologicals.2016.04.007_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"Heier","year":"2013","journal-title":"Sleep Med"},{"issue":"26","key":"10.1016\/j.biologicals.2016.04.007_bib9","article-title":"Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy","volume":"16","year":"2011","journal-title":"Euro Surveillance"},{"issue":"11","key":"10.1016\/j.biologicals.2016.04.007_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/dmcn.12522","article-title":"Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in England","volume":"56","author":"Winstone","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.biologicals.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.vaccine.2012.12.015","article-title":"The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns","volume":"31","author":"Wijnans","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.biologicals.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.biologicals.2016.04.007_bib13","article-title":"Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data","volume":"19","author":"Harris","year":"2014","journal-title":"Euro Surveillance"},{"issue":"20","key":"10.1016\/j.biologicals.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0000000000000987","article-title":"Vaccine safety Datalink narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States","volume":"83","author":"Duffy","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biologicals.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/joim.12150","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up","volume":"275","author":"Persson","year":"2014","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.biologicals.2016.04.007_bib16","doi-asserted-by":"crossref","unstructured":"Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 2011 Oct 12;343:d5956. http:\/\/dx.doi.org\/10.1136\/bmj.d5956.","DOI":"10.1136\/bmj.d5956"},{"issue":"4","key":"10.1016\/j.biologicals.2016.04.007_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/joim.12391","article-title":"A\u00a0coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden","volume":"278","author":"Feltelius","year":"2015","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.biologicals.2016.04.007_bib18","first-page":"1","article-title":"Pandemrix\u2122 and narcolepsy: a critical appraisal of the observational studies","author":"Verstraeten","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.biologicals.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/hv.27412","article-title":"Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal","volume":"10","author":"van der Most","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"294","key":"10.1016\/j.biologicals.2016.04.007_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.biologicals.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/dmcn.12543","article-title":"The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation","volume":"56","author":"Johansen","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"10.1016\/j.biologicals.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","article-title":"Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk","volume":"9","author":"Vaarala","year":"2014","journal-title":"PLoS One"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T17:01:11Z","timestamp":1572973271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105616300203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1045105616300203"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.04.007","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}